Search results for:
ondansetron
ondansetron
| Drug Name |
Form |
Strength |
Notes |
| Ondansetron |
SOLUTION, INJECTABLE |
2 mg/mL |
|
| Ondansetron |
SOLUTION, INTRAVENOUS |
32 mg/50 mL-D5% |
|
| Ondansetron |
SOLUTION, ORAL |
4 mg/5 mL |
|
| Ondansetron |
TABLET, DISINTEGRATING, ORAL |
4 mg |
|
| Ondansetron |
TABLET, DISINTEGRATING, ORAL |
8 mg |
|
| Ondansetron |
TABLET, ORAL |
4 mg |
|
| Zofran |
|
|
|
Last updated: Dec. 9, 2020
Add Formweb to your mobile device
Adult Patients: IV ondansetron single dose NOT to exceed 16 mg. See FDA Drug Safety Communication
Pediatric patients: IV ondansetron dosing NOT to exceed 0.25 mg/kg/dose (maximum: 16 mg) with a daily maximum of 0.5 mg/kg. See Drug Monograph.
May be given via hypodermoclysis (HDC/subcutaneous infusion). See Procedure 904.4991